Objective:

To learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

Approach:

• Study Design: Participants will undergo CT scans for radiation treatment planning, receive tumor biopsies, and receive 5 radiation treatments every other day over a 2-week period.
• Inclusion Criteria: Patients must have histologically or cytologically-confirmed locally advanced unresectable pancreatic ductal adenocarcinoma (PDA) and meet specific NCCN criteria.
• Exclusion Criteria: Patients with metastatic disease, prior radiation therapy for pancreatic cancer, or certain medical histories are excluded.

Key Findings:

• ART aims to improve targeting of aggressive cancer cells while protecting healthy tissue.
• The study will assess the reduction of side effects during treatment.

Interpretation:

The trial seeks to evaluate the safety and efficacy of ART in a specific patient population.

Limitations:

• Exclusion of patients with prior treatments may limit generalizability.
• Specific eligibility criteria may restrict participant diversity.

Conclusion:

The study aims to evaluate the safety and efficacy of ART in patients with locally advanced unresectable pancreatic cancer.

Sources:

• ClinicalTrials.gov